Protective role of plant sterol and stanol esters in liver inflammation: Insights from mice and humans e110758

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Plat, Jogchum ^a   Hendrikx, Tim ^a   Bieghs, Veerle ^a   Jeurissen, Mike L J ^a   Walenbergh, Sofie M A ^a   Van Gorp, Patrick J ^a   De Smet, Els ^a   Konings, Maurice ^a   Vreugdenhil, Anita C E ^a   Guichot, Yasmin Dias ^a   Rensen, Sander S ^a   Buurman, Wim A ^a   Greve, Jan Willem M ^a,c   Lütjohann, Dieter ^b   Mensink, Ronald P ^a   Shiri Sverdlov, Ronit ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF BONN   (Germany)

^c Zuyderland Medical Centre   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER G1; CAMPESTANOL; CAMPESTEROL; DESMOSTEROL; LATHOSTEROL; LIVER X RECEPTOR ALPHA; PHYTOSTEROL; SITOSTANOL; SITOSTEROL; STANOL ESTER; TUMOR NECROSIS FACTOR ALPHA; CHOLESTEROL; FAT INTAKE;

ABCA1 GENE; ABCG1 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYTOKINE RELEASE; DIETARY INTAKE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIPID DIET; LIVER BIOPSY; LIVER PROTECTION; LXRALPHA GENE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENESIS; ADVERSE EFFECTS; ANIMAL; FAT INTAKE; FEMALE; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; LIVER; MACROPHAGE; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; PHARMACOLOGY;

ANIMALS; CHOLESTEROL; DESMOSTEROL; DIETARY FATS; FEMALE; HUMANS; INFLAMMATION; LIVER; MACROPHAGES; MICE; MICE, KNOCKOUT; NON-ALCOHOLIC FATTY LIVER DISEASE; PHYTOSTEROLS;

EID: 84908691402     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110758     Document Type: Article

References (22)

1. Bayard M, Holt J, Boroughs E (2006) Nonalcoholic fatty liver disease. American family physician 73: 1961-1968.
2. Ostlund RE Jr (2002) Phytosterols in human nutrition. Annual review of nutrition 22: 533-549.
3. Baumgartner S, Mensink RP, Plat J (2011) Plant sterols and stanols in the treatment of dyslipidemia: new insights into targets and mechanisms related to cardiovascular risk. Current pharmaceutical design 17: 922-932.
4. Wouters K, van Gorp PJ, Bieghs V, Gijbels MJ, Duimel H, et al. (2008) Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 48: 474-486.
5. Simonen M, Männistö V, Leppänen J, Kaminska D, Kärjä V, et al. (2013) Desmosterol in human nonalcoholic steatohepatitis. Hepatology 58: 976-982.
6. Spann NJ, Garmire LX, McDonald JG, Myers DS, Milne SB, et al. (2012) Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 151: 138-52.
7. Bieghs V, Verheyen F, van Gorp PJ, Hendrikx T, Wouters K, et al. (2012) Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells. PloS one 7: e34378.
8. Brull F, Mensink RP, Steinbusch MF, Husche C, Lutjohann D, et al. (2012) Beneficial effects of sitostanol on the attenuated immune function in asthma patients: results of an in vitro approach. PloS one 7: e46895.
9. Brull F, Mensink RP, van den Hurk K, Duijvestijn A, Plat J (2010) TLR2 activation is essential to induce a Th1 shift in human peripheral blood mononuclear cells by plant stanols and plant sterols. The Journal of Biological Chemistry 285: 2951-2958.
10. Wouters K, van Bilsen M, van Gorp PJ, Bieghs V, Lutjohann D, et al. (2010) Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice. FEBS letters 584: 1001-1005.
11. Plat J, Nichols JA, Mensink RP (2005) Plant sterols and stanols: effects on mixed micellar composition and LXR (target gene) activation. J Lipid Res 46: 2468-76.
12. Yang C, Yu L, Li W, Xu F, Cohen JC, et al. (2004) Disruption of cholesterol homeostasis by plant sterols. J Clin Invest 114: 813-22.
13. Mouzaki M, Comelli E, Arendt B, Bonengel J, Fung S, et al. (2013) Intestinal microbiota in patients with non-alcoholic fatty liver disease. Hepatology 58: 120-127.
14. Martinez I, Perdicaro DJ, Brown AW, Hammons S, Carden TJ, et al. (2013) Diet-induced alterations of host cholesterol metabolism are likely to affect the gut microbiota composition in hamsters. Applied and environmental microbiology 79: 516-524.
15. Yoneda M, Fujita K, Nozaki Y, Endo H, Takahashi H, et al. (2010) Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study. Hepatol Res 40: 566-73.
16. Bieghs V, Wouters K, van Gorp PJ, Gijbels MJ, de Winther MP, et al. (2010) Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemie mice. Gastroenterology 138: 2477-2486.
17. Bieghs V, Hendrikx T, van Gorp PJ, Verheyen F, Guichot YD, et al. (2013) The cholesterol derivative 27-hydroxycholesterol reduces steatohepatitis in mice. Gastroenterology 144: 167-178.
18. Thelen KM, Laaksonen R, Päivä H, Lehtimäki T, Lütjohann D (2006) High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels. J Clin Pharmacol 46: 812-6.
19. Kanters E, Pasparakis M, Gijbels MJ, Vergouwe MN, Partouns-Hendriks I, et al. (2003) Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. The Journal of Clinical Investigation 112: 1176-1185.
20. Rensen SS, Slaats Y, Driessen A, Peutz-Kootstra CJ, Nijhuis J, et al. (2009) Activation of the complement system in human nonalcoholic fatty liver disease. Hepatology 50: 1809-17.
21. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94: 2467-74.
22. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. (2005) Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-21.